Why BGPT?
logo

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to start review



    Explore by Goal












     Quick Explanation


    Core claim (skeptically assessed)
    The paper argues that MYH7/G256E increases ADP affinity and makes ADP.Mg²⁺ harder to release from an actin-bound post-powerstroke-like state, which then prolongs the early/slow phase of myofibril relaxationβ€”i.e., impaired ADP release blunts product inhibition by elevated ADP.
    The evidence is consistent across (i) atomistic MD + sMD, (ii) stopped-flow competitive ADP/ATP binding to Ξ²-sS1, and (iii) hiPSC-CM-derived myofibril relaxation kinetics under ADP challenge. However, unloaded/low-load experiments and truncated constructs limit mapping to in vivo sarcomere mechanics.



     Long Explanation


    Paper Review (Raw-full-text extracted): β€œThe G256E HCM mutation prolongs relaxation via altered nucleotide handling”
    Target mechanism: ADP.Mg²⁺ release impairment from an actin-bound post-powerstroke-like state β†’ prolonged relaxation.
    Source BioRxiv: 10.1101/2025.08.29.673178
    1) What the paper claims (mechanism-level)
    • MD: G256E alters nucleotide-pocket dynamics; ADP tends to adopt a more stable conformation with new contacts involving Switch-1 and the SH1-loop, with loss of contacts to P-loop/purine-ring (as described in results).
    • sMD: ADP.Mg²⁺ displacement from the pocket requires more work/free-energy barrier in G256E (reported ~1.5Γ— higher work and higher Jarzynski-averaged barrier values).
    • Biochemical stopped-flow: Competitive ATP/ADP binding assays yield an increased apparent ADP affinity for G256E Ξ²-sS1 (~30% increase in KADP).
    • Myofibril kinetics: G256E myofibrils display faster force development/greater force and slower early/slow relaxation under ATP-only conditions; elevated ADP strongly slows WT early/slow relaxation but has little additional effect in G256Eβ€”interpreted as blunted product inhibition due to already impaired ADP release.
    2) Data visualization (from extracted numerical values in your provided research-data)
    These plots use only the numbers present in the provided extracted dataset snippet (e.g., KADP means, sMD work values, and stated qualitative force/kinetics trends).
    3) Logic chain: from atomic-scale barrier β†’ macroscopic relaxation phenotype
    Atomic-scale
    The authors model an actin-bound post-powerstroke-like state and argue that G256E strengthens ADP.Mg²⁺ coordination (new Switch-1/SH1-loop contacts) and increases the work needed to pull ADP out of the pocket using steered MD.
    Biochemical validation
    They validate ADP binding/affinity with a stopped-flow competitive assay on purified Ξ²-sS1, finding increased apparent ADP affinity in the mutant.
    Myofibril phenotype
    They then connect ADP handling to relaxation kinetics by measuring early/slow relaxation rates in hiPSC-CM-derived myofibrils, using elevated ADP as a product-inhibition challenge. WT shows strong slowing with added ADP, while G256E shows minimal additional slowing (interpreted as already impaired ADP release).
    4) Critical appraisal (skeptical, error-aware, mechanism-specific)
    Strengths
    • Multiscale convergence: The work links atomistic structural/dynamical predictions to biochemical ADP affinity and then to myofibril relaxation kinetics using an ADP product-inhibition strategy.
    • Explicit cross-validation: The authors explicitly attempt to validate a mechanistic MD prediction (ADP affinity/dynamics) with stopped-flow data, rather than treating MD as purely descriptive.
    • State awareness: The modeling focuses on an actin-bound post-powerstroke-like state, and the paper emphasizes that single-state structural analysis may mislead.
    Limitations & blind spots (where conclusions could be incomplete)
    • Unloaded/low-load experimental context: The paper acknowledges that stopped-flow biochemical experiments use isolated actomyosin constructs without effective load, which can affect ADP release kinetics; therefore, mapping β€œrate-limiting” steps in vivo is uncertain.
    • Truncation & missing sarcomeric complexity: The MD model includes an actin pentamer and myosin residues 1–810, excludes many thin-filament regulatory components, and omits load and full sarcomere constituents, which could influence ADP release pathways.
    • Timescale/trajectory sensitivity: While 3 Β΅s total conventional MD sampling per system (triplicate 500 ns) is substantial for all-atom studies, rare events and longer-timescale conformational transitions may still not be fully captured; the authors themselves mention potential timescale limitations when discussing SH1-loop structural alterations.
    • ADP challenge interpretation isn’t unique: Elevated ADP may affect multiple steps (not only ADP release) in the cross-bridge cycle; the paper attempts to argue ADP release as the main driver but also explicitly notes that other contributions (e.g., ATP binding/detachment rates) cannot be fully ruled out from the current measurements.
    • Data availability & independent reanalysis: The publicationStmt indicates availability status as β€œunknown,” and no accession numbers for MD trajectories/kinetic traces are provided in the extracted text. This reduces ease of independent replication/trajectory reanalysis.
    5) β€œWhat would disprove/shift” the main conclusion?
    • If G256E does not exhibit impaired ADP release under load-bearing physiological conditions (e.g., tension-dependent detachment measurements), then the proposed ADP-release causality would be weakened.
    • If additional experiments show that elevated ADP affects relaxation kinetics primarily via ATP binding or detachment geometry rather than ADP release, the blunted product inhibition interpretation could be reattributed.
    • If independent reanalysis of the sMD reaction coordinate (or alternative reaction coordinates / enhanced sampling strategies) yields qualitatively different β€œrelease barriers” for WT vs G256E, the computational mechanistic mapping would require revision.
    Run fully-independent science agent (optional)
    This agent will re-synthesize the mechanistic chain, check for internal consistency across reported numeric values, and propose falsifiable follow-ups based strictly on the provided full-text.


    Feedback:    

    Updated: April 15, 2026

     BGPT Paper Review


    Study Novelty

    90%

    High novelty comes from explicitly modeling and steered-displacement of Mg²⁺-ADP release from an actin-bound post-powerstroke-like state with an atomic, state-specific reaction coordinate, then validating that specific mechanistic step experimentally (ADP affinity and product-inhibition-shaped relaxation kinetics).


    Scientific Quality

    80%

    Overall strong multiscale coherence (MD/sMD β†’ stopped-flow KADP β†’ myofibril relaxation with ADP challenge) and explicit limitations. Quality would improve with published data accessibility/trajectories, load-matched biochemical kinetics, and stronger disentangling of ADP-release vs ATP-binding/detachment contributions.


    Study Generality

    70%

    Mechanistic framework (chemo-mechanical state modeling + experimental step validation) should generalize to other myosin mutations, but the specific conclusions for G256E depend on the experimental system and modeling choices (unloaded actomyosin, truncated constructs, missing regulatory proteins).


    Study Usefulness

    80%

    Useful for researchers studying HCM sarcomere kinetics because it pinpoints a concrete, experimentally testable step (ADP release/ADP product inhibition response) and provides mechanistic residue/interaction hypotheses tied to kinetics.


    Study Reproducibility

    70%

    Methods are relatively detailed (MD protocol, sMD setup, stopped-flow conditions, assay buffers, sample sizes are described). Reproducibility is reduced by missing explicit data accession/availability and by reliance on constructed models/parameters not fully enumerated in the excerpt (though standard AMBER/force-field choices are given in the text).


    Explanatory Depth

    90%

    The work provides a detailed mechanistic explanation: G256E β†’ altered ADP pocket conformation/contacts β†’ increased work/free-energy barrier for release β†’ increased ADP affinity β†’ altered relaxation kinetics under ADP challenge. It also acknowledges alternative step contributions.


    🎁 Authors: Collect 500 Free Science Tokens (β‰ˆ $50.0 USD)

    Claim My Author Tokens

    Use for 125 days of free BGPT access (4 tokens = 1 day) or trade/sell (β‰ˆ $50.0 USD)

     Analysis Wizard



    It will parse the extracted numeric summaries for KADP and sMD work values, compute effect sizes (fold and % change), and render publication-style Plotly comparisons across WT vs G256E using only provided numbers.



     Hypothesis Graveyard


    β€œThe phenotype is mainly due to increased Ca²⁺ sensitivity alone.” The paper reports increased force but argues relaxation slowing links to impaired ADP release and blunted ADP product inhibition; if future load-matched kinetics show relaxation is unaffected when ADP handling is controlled, this would weaken the ADP-release-centric explanation.


    β€œADP release is not causally related; any ADP affinity change is incidental.” This would be falsified if manipulations that specifically equalize ADP affinity/occupancy between WT and G256E remove the relaxation phenotype while leaving pocket structure otherwise perturbed.

     Science Art


    Paper Review: The G256E HCM mutation prolongs relaxation via altered nucleotide handling Science Art

     Science Movie


    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT






     Trending